Journal of Thrombosis and Thrombolysis

, Volume 29, Issue 3, pp 322–325

Effectiveness of enoxaparin for prevention of radial artery occlusion after transradial cardiac catheterization

  • Hasan Feray
  • Cemil Izgi
  • Diler Cetiner
  • Ebubekir Emre Men
  • Yelda Saltan
  • Ayhan Baltay
  • Reyhan Kahraman
Article

Abstract

The aim of this study was to assess the efficacy of enoxaparin for prevention of radial artery (RA) occlusion after transradial access for diagnostic and interventional cardiac procedures. RA occlusion is a potential complication of transradial cardiac catheterization. Conventionally, unfractionated heparin is used for prevention of RA occlusion. Effectiveness of low molecular weight heparins for prevention of this complication has not been tested before. Fifty transradial catheterizations were performed for diagnostic and/or interventional cardiac procedures in 39 patients. All the patients received 60 mg enoxaparin through the radial sheath at the beginning of the procedure for prevention of RA occlusion. RA patency was evaluated by Doppler examination. Patients were assessed for postprocedural RA occlusion at discharge and 5.5 ± 2.8 days follow-up. RA occlusion was detected after 2 of the 50 transradial accesses, yielding a RA occlusion rate of % 4. In this study we found a low rate of RA occlusion with use of enoxaparin during transradial access. Enoxaparin is safe and effective in transradial procedures with a RA occlusion rate comparable to use of unfractionated heparin.

Keywords

Transradial Radial artery Complication Thrombosis Enoxaparin Angiography Angioplasty 

References

  1. 1.
    Archbold RA, Robinson NM, Schilling RJ (2004) Radial artery access for coronary angiography and percutaneous coronary intervention. BMJ 329:443–446. doi:10.1136/bmj.329.7463.443 CrossRefPubMedGoogle Scholar
  2. 2.
    Kiemeneij F, Laarman GJ, de Melker E (1995) Transradial artery coronary angioplasty. Am Heart J 129:1–7. doi:10.1016/0002-8703(95)90034-9 CrossRefPubMedGoogle Scholar
  3. 3.
    Stella PR, Kiemeneij F, Laarman GJ et al (1997) Incidence and outcome of radial artery occlusion following transradial artery coronary angioplasty. Cathet Cardiovasc Diagn 40:156–158. doi:10.1002/(SICI)1097-0304(199702)40:2<156::AID-CCD7>3.0.CO;2-A CrossRefPubMedGoogle Scholar
  4. 4.
    Pancholy SB (2007) Transradial access in an occluded radial artery: new technique. J Invasive Cardiol 19:541–544PubMedGoogle Scholar
  5. 5.
    Spaulding C, Lefèvre T, Funck F et al (1996) Left radial approach for coronary angiography: results of a prospective study. Cathet Cardiovasc Diagn 39:365–370. doi:10.1002/(SICI)1097-0304(199612)39:4<365::AID-CCD8>3.0.CO;2-B CrossRefPubMedGoogle Scholar
  6. 6.
    Diez JG (2008) Practical issues on the use of enoxaparin in elective and emergent percutaneous coronary intervention. J Invasive Cardiol 20:482–489PubMedGoogle Scholar
  7. 7.
    Bedford RF, Wollman H (1973) Complications of percutaneous radial artery cannulation:An objective prospective study in man. Anesthesiology 38:228–236. doi:10.1097/00000542-197303000-00006 CrossRefPubMedGoogle Scholar
  8. 8.
    Nagai S, Abe S, Sato T et al (1999) Ultrasonic assessment of vascular complications in coronary angiography and angioplasty after transradial approach. Am J Cardiol 83:180–186. doi:10.1016/S0002-9149(98)00821-2 CrossRefPubMedGoogle Scholar
  9. 9.
    Pancholy S, Coppola J, Patel T et al (2008) Prevention of radial artery occlusion-Patent hemostasis evaluation trial (PROPHET Study): a randomized comparison of traditional versus patency documented hemostasis after transradial catheterization. Catheter Cardiovasc Interv 72:335–340. doi:10.1002/ccd.21639 CrossRefPubMedGoogle Scholar
  10. 10.
    Vankatesh K, Mann T (2006) Transitioning from heparin to bivalirudin in patients undergoing ad hoc transradial interventional procedures: a pilot study. J Invasive Cardiol 18:120–124Google Scholar
  11. 11.
    Borentain M, Montalescot G, Bouzamondo A et al (2005) Low-molecular-weight heparin vs. unfractionated heparin in percutaneous coronary intervention: a combined analysis. Catheter Cardiovasc Interv 65:212–221. doi:10.1002/ccd.20352 CrossRefPubMedGoogle Scholar
  12. 12.
    Petersen JL, Mahaffey KW, Hasselblad V et al (2004) Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. JAMA 292:89–96. doi:10.1001/jama.292.1.89 CrossRefPubMedGoogle Scholar
  13. 13.
    Choussat R, Black A, Bossi I et al (2000) Vascular complications and clinical outcome after coronary angioplasty with platelet Iıb/IIIa receptor blockade: comparison of transradial vs transfemoral arterial access. Eur Heart J 21:662–667. doi:10.1053/euhj.1999.1945 CrossRefPubMedGoogle Scholar
  14. 14.
    Cantor WJ, Mahaffey KW, Huang Z et al (2007) Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal. Catheter Cardiovasc Interv 69:73–83. doi:10.1002/ccd.20897 CrossRefPubMedGoogle Scholar
  15. 15.
    Ferguson JJ, Califf RM, Antman EM et al (2004) Enoxaparin vs unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy. Primary results of the SYNERGY randomized trial. JAMA 292:45–54. doi:10.1001/jama.292.1.45 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Hasan Feray
    • 1
  • Cemil Izgi
    • 1
    • 2
  • Diler Cetiner
    • 1
  • Ebubekir Emre Men
    • 1
  • Yelda Saltan
    • 1
  • Ayhan Baltay
    • 1
  • Reyhan Kahraman
    • 1
  1. 1.Department of CardiologyGaziosmanpasa HospitalIstanbulTurkey
  2. 2.Moda, KadikoyTurkey

Personalised recommendations